346 related articles for article (PubMed ID: 19154979)
1. Prediction of seed migration after transperineal interstitial prostate brachytherapy with I-125 free seeds.
Sugawara A; Nakashima J; Shigematsu N; Kunieda E; Kubo A
Brachytherapy; 2009; 8(1):52-6. PubMed ID: 19154979
[TBL] [Abstract][Full Text] [Related]
2. Seed migration after transperineal interstitial prostate brachytherapy with I-125 free seeds: analysis of its incidence and risk factors.
Miyazawa K; Matoba M; Minato H; Morita N; Chikazawa I; Ota K; Tokunaga K; Tonami H; Nojima T; Suzuki K
Jpn J Radiol; 2012 Oct; 30(8):635-41. PubMed ID: 22798169
[TBL] [Abstract][Full Text] [Related]
3. Reduction of pulmonary migration of permanent interstitial sources in patients undergoing prostate brachytherapy.
Stone NN; Stock RG
Urology; 2005 Jul; 66(1):119-23. PubMed ID: 15992909
[TBL] [Abstract][Full Text] [Related]
4. Prostate brachytherapy seed migration and dosimetry: analysis of stranded sources and other potential predictive factors.
Fuller DB; Koziol JA; Feng AC
Brachytherapy; 2004; 3(1):10-9. PubMed ID: 15110308
[TBL] [Abstract][Full Text] [Related]
5. A study of a pretreatment method to predict the number of I-125 seeds required for prostate brachytherapy.
Al-Qaisieh B; Brearley E; St Clair S; Flynn A
Int J Radiat Oncol Biol Phys; 2006 May; 65(1):304-7. PubMed ID: 16618585
[TBL] [Abstract][Full Text] [Related]
6. Seed migration after transperineal interstitial prostate brachytherapy by using loose seeds: Japanese prostate cancer outcome study of permanent iodine-125 seed implantation (J-POPS) multi-institutional cohort study.
Nakano M; Yorozu A; Saito S; Sugawara A; Maruo S; Kojima S; Kikuchi T; Fukushima M; Dokiya T; Yamanaka H
Radiat Oncol; 2015 Nov; 10():228. PubMed ID: 26577301
[TBL] [Abstract][Full Text] [Related]
7. Sequential comparison of seed loss and prostate dosimetry of stranded seeds with loose seeds in 125I permanent implant for low-risk prostate cancer.
Saibishkumar EP; Borg J; Yeung I; Cummins-Holder C; Landon A; Crook J
Int J Radiat Oncol Biol Phys; 2009 Jan; 73(1):61-8. PubMed ID: 18823713
[TBL] [Abstract][Full Text] [Related]
8. Migration of prostate brachytherapy seeds to the vertebral venous plexus.
Nakano M; Uno H; Gotoh T; Kubota Y; Ishihara S; Deguchi T; Hayashi S; Matsuo M; Tanaka O; Hoshi H
Brachytherapy; 2006; 5(2):127-30. PubMed ID: 16644468
[TBL] [Abstract][Full Text] [Related]
9. A dosimetric analysis of unstranded seeds versus customized stranded seeds in transperineal interstitial permanent prostate seed brachytherapy.
Heysek RV; Gwede CK; Torres-Roca J; Cantor A; Kelley S; Saini AS; Pow-Sang J
Brachytherapy; 2006; 5(4):244-50. PubMed ID: 17118318
[TBL] [Abstract][Full Text] [Related]
10. Factors predicting for urinary morbidity following 125iodine transperineal prostate brachytherapy.
Williams SG; Millar JL; Duchesne GM; Dally MJ; Royce PL; Snow RM
Radiother Oncol; 2004 Oct; 73(1):33-8. PubMed ID: 15465143
[TBL] [Abstract][Full Text] [Related]
11. Is a loose-seed nomogram still valid for prostate brachytherapy in a stranded-seed era?
Kudchadker RJ; Swanson DA; Kuban DA; Lee AK; Bruno TL; Frank SJ
Int J Radiat Oncol Biol Phys; 2008 Oct; 72(2):623-7. PubMed ID: 18410998
[TBL] [Abstract][Full Text] [Related]
12. [Physical basics and clinical realization of interstitial brachytherapy of the prostate with iodine 125].
Kaulich TW; Lamprecht U; Paulsen F; Kahmann F; Maurer U; Henkel TO; Loeser W; Bichler KH; Nüsslin F; Bamberg M
Strahlenther Onkol; 2002 Oct; 178(10):548-55. PubMed ID: 12386786
[TBL] [Abstract][Full Text] [Related]
13. Impact of intraoperative edema during transperineal permanent prostate brachytherapy on computer-optimized and preimplant planning techniques.
Yamada Y; Potters L; Zaider M; Cohen G; Venkatraman E; Zelefsky MJ
Am J Clin Oncol; 2003 Oct; 26(5):e130-5. PubMed ID: 14528087
[TBL] [Abstract][Full Text] [Related]
14. An analysis of the relation between physical characteristics of prostate I-125 seed implants and lower urinary tract symptoms: bladder hotspot dose and prostate size are significant predictors.
Steggerda MJ; van der Poel HG; Moonen LM
Radiother Oncol; 2008 Jul; 88(1):108-14. PubMed ID: 18039548
[TBL] [Abstract][Full Text] [Related]
15. Improvements in prostate brachytherapy dosimetry due to seed stranding.
Lin K; Lee SP; Cho JS; Reiter RE; DeMarco JJ; Solberg TD
Brachytherapy; 2007; 6(1):44-8. PubMed ID: 17284385
[TBL] [Abstract][Full Text] [Related]
16. AnchorSeed for the reduction of source movement in prostate brachytherapy with the Mick applicator implant technique.
Badwan HO; Shanahan AE; Adams MA; Shanahan TG; Mueller PW; Markwell SJ; Tarter TH
Brachytherapy; 2010; 9(1):23-6. PubMed ID: 19762286
[TBL] [Abstract][Full Text] [Related]
17. Dosimetry accuracy as a function of seed localization uncertainty in permanent prostate brachytherapy: increased seed number correlates with less variability in prostate dosimetry.
Su Y; Davis BJ; Furutani KM; Herman MG; Robb RA
Phys Med Biol; 2007 Jun; 52(11):3105-19. PubMed ID: 17505092
[TBL] [Abstract][Full Text] [Related]
18. A comparative study of seed localization and dose calculation on pre- and post-implantation ultrasound and CT images for low-dose-rate prostate brachytherapy.
Ali I; Algan O; Thompson S; Sindhwani P; Herman T; Cheng CY; Ahmad S
Phys Med Biol; 2009 Sep; 54(18):5595-611. PubMed ID: 19717887
[TBL] [Abstract][Full Text] [Related]
19. Prostate implant dosimetric outcomes and migration patterns between bio-absorbable coated and uncoated brachytherapy seeds.
Sarkar A; Donavanik V; Zhang I; Chen H; Koprowski C; Hanlon A; Mourtada F; Strasser J; Raben A
Brachytherapy; 2013; 12(4):356-61. PubMed ID: 23477885
[TBL] [Abstract][Full Text] [Related]
20. Incidence of seed migration to the chest, abdomen, and pelvis after transperineal interstitial prostate brachytherapy with loose (125)I seeds.
Sugawara A; Nakashima J; Kunieda E; Nagata H; Mizuno R; Seki S; Shiraishi Y; Kouta R; Oya M; Shigematsu N
Radiat Oncol; 2011 Oct; 6():130. PubMed ID: 21974959
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
